Preclinical research in the sector of pharma and biotechnology in getting a new revolution. Automated analysis of medical images is now becoming a gold standard to accelerate the processes of preclinical and clinical analysis.
Business France, the Biotech French Trade Office in Boston is pride to welcome Olivier Julé, CEO of Biocellvia a company focused on digital automated images for respiratory diseases. Thanks to their technology they have been able to support images analysis in IPF – COPD (Emphysema) – COPD (Small airway remodelling) – Asthma.
Olivier will be here in Boston to share how Biocellvia’s technology can support your projects o have discussion about how Digital analysis is now able to support your drug developments and to share case studies and experineces.
For more informationhttp : //www.biocellvia.com/
In case of questions, feel free to reach Alexandre Blanchot – French Trade Advisor Biotech
This event is adressed to : Scientists – Physicians in respiratory – Persons involved in preclinical research – Executive levels of biotech and pharma that develop drugs in these indications
Don’t hesitate to share that to every person involved in Respiratory R&D
Send this to a friend